JULIA BEITER: Open Payments
NPI 1952181158 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,396 in 64 payments from 11 companies in 2025. Trend: 2023 $101 · 2024 $2,211 · 2025 $3,396
Food & beverage: $2,046Consulting: $1,350
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $1,949 |
| ABBVIE INC. | 32 | $649 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $237 |
| Janssen Scientific Affairs, LLC | 2 | $184 |
| EVOKE PHARMA, INC. | 2 | $129 |
| GENZYME CORPORATION | 2 | $122 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Celltrion USA Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: TREMFYA, SKYRIZI, ENTYVIO, CREON, RINVOQ, GIMOTI, DUPIXENT, XIFAXAN.
Industry payments across PA — which companies pay providers there.
